Patents by Inventor Matthew G. Fishler

Matthew G. Fishler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10993674
    Abstract: The present disclosure provides systems and methods for classifying signals of interest in a cardiac rhythm management (CRM) device. A CRM device includes an intrinsic activation sensing circuit configured to pass signals falling within a first passband, a crosstalk sensing circuit configured to pass signals falling within a second passband, wherein the second passband contains higher frequencies than the first passband, and a computing device communicatively coupled to the intrinsic activation sensing circuit and the crosstalk sensing circuit, the computing device configured to classify a signal of interest as one of an intrinsic activation signal and a crosstalk signal based on whether the signal of interest is passed by the intrinsic activation sensing circuit and the crosstalk sensing circuit.
    Type: Grant
    Filed: December 17, 2018
    Date of Patent: May 4, 2021
    Assignee: PACESETTER, INC.
    Inventors: Matthew G. Fishler, Gene A. Bornzin, Benjamin T. Persson, Kenneth J. Carroll
  • Patent number: 10987518
    Abstract: An implantable system including an atrial leadless pacemaker (aLP) and a ventricular leadless pacemaker (vLP), and methods for use therewith, are configured or used to terminate a pacemaker mediated tachycardia (PMT). One of the aLP or the vLP detects a PMT and informs the other one. The aLP initiates a PMT PA interval that is shorter than a PA interval that the aLP would otherwise use for atrial pacing if a PMT was not detected. The vLP initiates a PMT PV interval that is longer than the PMT PA interval. If an intrinsic atrial or ventricular event is detected before PMT PA interval or the PMT PV interval expires, then these intervals will be terminated, otherwise an atrial chamber will be paced if the PMT PA interval expires, and/or a ventricular chamber will be paced if the PMT PV interval expires. This should have the effect of terminating the PMT.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: April 27, 2021
    Assignee: Pacesetter, Inc.
    Inventors: Chunlan Jiang, Matthew G. Fishler
  • Publication number: 20210093863
    Abstract: Implantable medical devices (IMDs) described herein, and methods for use therewith described herein, reduce how often an IMD accepts a false message and/or reduce adverse effects of an IMD accepting a false message. Such IMDs can be leadless pacemakers (LPs), or implantable cardio defibrillators (ICDs), but are not limited thereto. Such embodiments can be used help multiple IMDs (e.g., multiple LPs) implanted within a same patient maintain synchronous operation, such as synchronous multi-chamber pacing.
    Type: Application
    Filed: September 16, 2020
    Publication date: April 1, 2021
    Applicant: Pacesetter, Inc.
    Inventors: Donald Chin, Matthew G. Fishler, Benjamin T. Persson, Suresh Gurunathan
  • Publication number: 20210093873
    Abstract: Implantable medical devices (IMDs) described herein, and methods for use therewith described herein, reduce how often an IMD accepts a false message and/or reduce adverse effects of an IMD accepting a false message. Such IMDs can be leadless pacemakers (LPs), or implantable cardio defibrillators (ICDs), but are not limited thereto. Such embodiments can be used help multiple IMDs (e.g., multiple LPs) implanted within a same patient maintain synchronous operation, such as synchronous multi-chamber pacing.
    Type: Application
    Filed: September 16, 2020
    Publication date: April 1, 2021
    Applicant: Pacesetter, Inc.
    Inventors: Donald Chin, Matthew G. Fishler, Benjamin T. Persson, Suresh Gurunathan
  • Publication number: 20200403429
    Abstract: Described herein are methods, devices, and systems that estimate a total amount of time it takes to discharge a battery of an IMD from initial to subsequent capacity levels, which total amount of time is indicative of a longevity of the IMD. In certain embodiments, a range of capacity levels for the battery is separated into N separate intervals. For each of the N intervals, an estimate of an amount of time it takes for the battery to discharge from a beginning to an end of the interval is determined, to thereby determine N amounts of time that are summed to estimate the total amount of time that it takes to discharge the battery from the initial to subsequent capacity levels. In other embodiments, an iterative equation is used to estimate the total amount of time takes it takes to discharge the battery from the initial to subsequent capacity levels.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 24, 2020
    Applicant: Pacesetter, Inc.
    Inventor: Matthew G. Fishler
  • Publication number: 20200403717
    Abstract: Described herein is an implantable medical device (IMD) that wirelessly communicates another IMD, and methods for use therewith. Such a method can include receiving one or more implant-to-implant (i2i) communication signals from the other IMD using a communication receiver of the IMD, measuring a strength of at least one of the one or more received i2i communication signals or a surrogate thereof, and updating a strength metric based on the measured strength or surrogate thereof. The method further includes determining, based on the updated strength metric, whether to increase, decrease, or maintain the sensitivity of the communication receiver of the IMD, and responding accordingly such that the sensitivity is sometimes increased, sometimes decreased, and sometimes maintained. The method can also include selectively causing a transmitter of the IMD to transmit an i2i communication signal to the other IMD requesting that the other IMD adjust its transmission strength.
    Type: Application
    Filed: June 9, 2020
    Publication date: December 24, 2020
    Applicant: Pacesetter, Inc.
    Inventors: Matthew G. Fishler, Benjamin T. Persson, Suresh Gurunathan
  • Publication number: 20200215341
    Abstract: An implantable system includes a first leadless pacemaker (LP1) implanted in or on a first chamber of a heart and a second leadless pacemaker (LP2) implanted in or on a second chamber of the heart. The LP1 uses at least two of its electrodes to transmit and receive implant-to-implant (i2i) messages to and from the LP2. During one or more periods of time, the LP1 times delivery of pacing pulse(s) to the first chamber of the heart based on timing of cardiac activity associated with the second chamber of the heart detected by the LP1 itself. During one or more further periods of time, the LP1 times delivery of pacing pulse(s) to the first chamber of the heart based on timing of cardiac activity associated with the second chamber of the heart as determined based on one or more i2i messages received by the LP1 from the LP2.
    Type: Application
    Filed: January 7, 2019
    Publication date: July 9, 2020
    Applicant: Pacesetter, Inc.
    Inventors: Xiaoyi Min, Matthew G. Fishler
  • Publication number: 20200215340
    Abstract: An implantable system including an atrial leadless pacemaker (aLP) and a ventricular leadless pacemaker (vLP), and methods for use therewith, are configured or used to terminate a pacemaker mediated tachycardia (PMT). One of the aLP or the vLP detects a PMT and informs the other one. The aLP initiates a PMT PA interval that is shorter than a PA interval that the aLP would otherwise use for atrial pacing if a PMT was not detected. The vLP initiates a PMT PV interval that is longer than the PMT PA interval. If an intrinsic atrial or ventricular event is detected before PMT PA interval or the PMT PV interval expires, then these intervals will be terminated, otherwise an atrial chamber will be paced if the PMT PA interval expires, and/or a ventricular chamber will be paced if the PMT PV interval expires. This should have the effect of terminating the PMT.
    Type: Application
    Filed: January 3, 2019
    Publication date: July 9, 2020
    Applicant: Pacesetter, Inc.
    Inventors: Chunlan Jiang, Matthew G. Fishler
  • Publication number: 20200215339
    Abstract: Embodiments described herein relate to implantable medical devices (IMDs) and methods for use therewith. Such a method includes enabling a communication capability of an IMD during a message alert period and monitoring for a message while the communication capability is enabled during the message alert period. In response to receiving a message during the message alert period, there is a determination whether the message is valid or invalid. If the message is invalid, the message is ignored, and an invalid message count is incremented. A further message is monitored for during the message alert period occurs, when the invalid message count has not yet reached a corresponding invalid message count threshold. The communication capability of the IMD is disabled for a disable period, when the invalid message count reaches the corresponding invalid message count threshold. If a valid message is received, the IMD acts upon information included therein.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 9, 2020
    Applicant: Pacesetter, Inc.
    Inventors: Matthew G. Fishler, Benjamin T. Persson, Suresh Gurunathan
  • Publication number: 20200215337
    Abstract: An implantable system includes a first leadless pacemaker (LP1) implanted in or on a first chamber of a heart and a second leadless pacemaker (LP2) implanted in or on a second chamber of the heart. The LP1 is configured to time delivery of one or more pacing pulses delivered to the first chamber of the heart based on timing of cardiac activity associated with the second chamber of the heart detected by the LP1 itself. The LP1 is also configured to transmit implant-to-implant (i2i) messages to the LP2. The LP2 is configured to time delivery of one or more pacing pulses delivered to the second chamber of the heart based on timing of cardiac activity associated with the second chamber of the heart as determined based on one or more i2i messages received by the LP2 from the LP1.
    Type: Application
    Filed: January 7, 2019
    Publication date: July 9, 2020
    Applicant: Pacesetter, Inc.
    Inventors: Xiaoyi Min, Matthew G. Fishler
  • Publication number: 20200215336
    Abstract: A leadless pacemaker (LP) is configured to be implanted in or on a cardiac chamber. The LP includes a first housing made of an electrically conductive material, a second housing made of an electrically conductive material, and an inter-housing insulator between the first and second housings and electrically isolating the first and second housings from one another. Electronic circuitry within the first housing includes pulse generator(s), sense amplifier(s), and a controller. A battery within the second housing provides power to the electronic circuitry via conductors that electrically couple poles of the battery to the electronic circuitry within the first housing. The LP includes two or more electrodes including at least one tip electrode and at least one ring electrode. At least two of the electrodes are selectively couplable to a pulse generator to enable delivery of pacing pulses to the cardiac chamber in or on which the LP is implanted.
    Type: Application
    Filed: January 7, 2019
    Publication date: July 9, 2020
    Applicant: Pacesetter, Inc.
    Inventors: Xiaoyi Min, Matthew G. Fishler
  • Publication number: 20200129763
    Abstract: A biostimulator, such as a leadless cardiac pacemaker, including an electrical feedthrough assembly mounted on a housing, is described. An electronics compartment of the housing can contain an electronics assembly to generate a pacing impulse, and the electrical feedthrough assembly can include an electrode tip to deliver the pacing impulse to a target tissue. A monolithically formed electrode body can have a pin integrated with a cup. The pin can be electrically connected to the electronics assembly, and the cup can be electrically connected to the electrode tip. Accordingly, the biostimulator can transmit the pacing impulse through the monolithic pin and cup to the target tissue. The cup can hold a filler having a therapeutic agent for delivery to the target tissue and may include retention elements for maintaining the filler at a predetermined location within the cup.
    Type: Application
    Filed: October 24, 2019
    Publication date: April 30, 2020
    Applicant: Pacesetter, Inc.
    Inventors: Paul Paspa, Thomas B. Eby, Matthew G. Fishler, Carl Lance Boling, Thomas Robert Luhrs, Russell Klehn, Tyler J. Strang, Arees Garabed, Kavous Sahabi, Brett Villavicencio, Wes Alleman, Alex Soriano, Matthew R. Malone, Conor P. Foley
  • Patent number: 10632315
    Abstract: Embodiments described herein relate to implantable medical devices (IMDs) and methods for use therewith. Such a method includes enabling a communication capability of an IMD during a message alert period and monitoring for a message while the communication capability is enabled during the message alert period. In response to receiving a message during the message alert period, there is a determination whether the message is valid or invalid. If the message is invalid, the message is ignored, and an invalid message count is incremented. A further message is monitored for during the message alert period occurs, when the invalid message count has not yet reached a corresponding invalid message count threshold. The communication capability of the IMD is disabled for a disable period, when the invalid message count reaches the corresponding invalid message count threshold. If a valid message is received, the IMD acts upon information included therein.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: April 28, 2020
    Assignee: Pacesetter, Inc.
    Inventors: Matthew G. Fishler, Benjamin T. Persson, Suresh Gurunathan
  • Publication number: 20200086129
    Abstract: Embodiments described herein relate to implantable medical devices (IMDs) and methods for use therewith. Such a method includes using an accelerometer of an IMD (e.g., a leadless pacemaker) to produce one or more accelerometer outputs indicative of the orientation of the IMD. The method can also include controlling communication pulse parameter(s) of one or more communication pulses (produced by pulse generator(s)) based on accelerator output(s) indicative of the orientation of the IMD. The communication pulse parameter(s) that is/are controlled can be, e.g., communication pulse amplitude, communication pulse width, communication pulse timing, and/or communication pulse morphology. Such embodiments can be used to improve conductive communications between IMDs whose orientation relative to one another may change over time, e.g., due to changes in posture and/or due to cardiac motion over a cardiac cycle.
    Type: Application
    Filed: October 25, 2018
    Publication date: March 19, 2020
    Inventors: XIAOYI MIN, DAVID LIGON, WEIQUN YANG, SHAWN CHEN, MATTHEW G. FISHLER
  • Publication number: 20200054880
    Abstract: Certain embodiments of the present technology disclosed herein relate to implantable systems, and methods for use therewith, that use a temperature sensor to initially detect an onset of patient activity, and then use a motion sensor to confirm or reject the initial detection of the onset of patient activity. Other embodiments of the present technology disclosed herein relate to implantable systems, and methods for use therewith, that use a motion sensor to initially detect an onset of patient activity, and then use a temperature sensor to confirm or reject the initial detection of the onset of patient activity. The use of both a motion sensor and a temperature sensor provides improvements over using just one of the types of sensors for rate responsive pacing.
    Type: Application
    Filed: July 12, 2019
    Publication date: February 20, 2020
    Inventors: Matthew G. Fishler, Paul Paspa
  • Publication number: 20190344088
    Abstract: Embodiments described herein relate to implantable medical devices (IMDs) and methods for use therewith. Such a method includes enabling a communication capability of an IMD during a message alert period and monitoring for a message while the communication capability is enabled during the message alert period. In response to receiving a message during the message alert period, there is a determination whether the message is valid or invalid. If the message is invalid, the message is ignored, and an invalid message count is incremented. A further message is monitored for during the message alert period occurs, when the invalid message count has not yet reached a corresponding invalid message count threshold. The communication capability of the IMD is disabled for a disable period, when the invalid message count reaches the corresponding invalid message count threshold. If a valid message is received, the IMD acts upon information included therein.
    Type: Application
    Filed: May 10, 2018
    Publication date: November 14, 2019
    Inventors: Matthew G. Fishler, Benjamin T. Persson, Suresh Gurunathan
  • Publication number: 20190329031
    Abstract: An implantable medical device is disclosed herein and can be in the form of an implantable medical lead or a leadless pulse generator. The implantable medical device includes a body, at least one electrode and a tube-cut helical fixation anchor. The body includes a distal end and a proximal end opposite the distal end. The at least one electrode is supported on the body. The tube-cut helical fixation anchor distally extends from the distal end. The tube-cut helical fixation anchor may be fixed or extendable/retractable relative to the distal end. The tube-cut helical fixation anchor may be a result of a manufacturing process comprising cutting the tube-cut helical fixation anchor from a thin-walled tubular body.
    Type: Application
    Filed: July 9, 2019
    Publication date: October 31, 2019
    Inventors: Ivan Ma, Bruce Weir, Matthew G. Fishler, Ott Khouengboua
  • Patent number: 10391306
    Abstract: An implantable medical device is disclosed herein and can be in the form of an implantable medical lead or a leadless pulse generator. The implantable medical device includes a body, at least one electrode and a tube-cut helical fixation anchor. The body includes a distal end and a proximal end opposite the distal end. The at least one electrode is supported on the body. The tube-cut helical fixation anchor distally extends from the distal end. The tube-cut helical fixation anchor may be fixed or extendable/retractable relative to the distal end. The tube-cut helical fixation anchor may be a result of a manufacturing process comprising cutting the tube-cut helical fixation anchor from a thin-walled tubular body.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: August 27, 2019
    Assignee: Pacesetter, Inc.
    Inventors: Ivan Ma, Bruce Weir, Matthew G. Fishler, Ott Khouengboua
  • Publication number: 20190134413
    Abstract: A biostimulator, such as a leadless cardiac pacemaker, including a fixation element to engage tissue and one or more backstop elements to resist back-out from the tissue, is described. The fixation element can be mounted on a housing of the biostimulator such that a helix of the fixation element extends distally to a leading point. The leading point can be located on a distal face of the helix at a position that is proximal from a center of the distal face. The backstop elements can include non-metallic filaments, such as sutures, or can include a pinch point of the biostimulator. The backstop features can grip the tissue to prevent unscrewing of the fixation element. Other embodiments are also described and claimed.
    Type: Application
    Filed: November 5, 2018
    Publication date: May 9, 2019
    Inventors: Craig E. Mar, Thomas B. Eby, Paul Paspa, Sondra Orts, Matthew G. Fishler, Stephen Lee, Carl Lance Boling, Thomas Robert Luhrs
  • Publication number: 20190117168
    Abstract: The present disclosure provides systems and methods for classifying signals of interest in a cardiac rhythm management (CRM) device. A CRM device includes an intrinsic activation sensing circuit configured to pass signals falling within a first passband, a crosstalk sensing circuit configured to pass signals falling within a second passband, wherein the second passband contains higher frequencies than the first passband, and a computing device communicatively coupled to the intrinsic activation sensing circuit and the crosstalk sensing circuit, the computing device configured to classify a signal of interest as one of an intrinsic activation signal and a crosstalk signal based on whether the signal of interest is passed by the intrinsic activation sensing circuit and the crosstalk sensing circuit.
    Type: Application
    Filed: December 17, 2018
    Publication date: April 25, 2019
    Inventors: Matthew G. Fishler, Gene A. Bornzin, Benjamin T. Persson, Kenneth J. Carroll